A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)
Clinical trial NCT01958671 · COMPLETED
Trial details
- NCT number
- NCT01958671
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-09
- Primary completion
- 2016-07-28
- Enrollment
- 461
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.